Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury

Experimental Eye Research

Volumn 76, Issue 2, 2003, Pages 161-167

  Yamada, Jun ^a   Dana, M Reza ^b   Sotozono, Chie ^a   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Alkali burns; Corneal wound healing; Cytokine; Interleukin; Neovascularization

Indexed keywords

ALKALI; FLUORESCENT DYE; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMICROSCOPY; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCISION; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANALYSIS; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZATION; RAT; RAT STRAIN; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; WOUND HEALING;

EID: 0037331786     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4835(02)00293-2     Document Type: Article

References (39)

1. BenEzra D., Maftzir G. Antibodies to IL-1 and TNF-alpha but not to bFGF inhibit angiogenesis. Invest. Ophthalmol. Vis. Sci. 37:1996;4664.
2. Boisjoly H.M., Laplante C., Bernatchez S.F., Salesse C., Giasson M., Joly M.C. Effects of EGF IL-1 and their combination on in vitro corneal epithelial wound closure and cell chemotaxis. Exp. Eye Res. 57:1993;293-300.
3. Cejkova J., Lojda Z., Salonen E.M., Vaheri A. Histochemical study of alkali-burned rabbit anterior eye segment in which severe lesions were prevented by aprotinin treatment. Histochemistry. 92:1989;441-448.
4. Chung J.H., Kang Y.G., Kim H.J. Effect of 0.1% dexamethasone on epithelial healing in experimental corneal alkali wounds: morphological changes during the repair process. Graefes. Arch. Clin. Exp. Ophthalmol. 236:1998;537-545.
5. Cubitt C.L., Lausch R.N., Oakes J.E. Differences in interleukin-6 gene expression between cultured human corneal epithelial cells and keratocytes. Invest. Ophthalmol. Vis. Sci. 36:1995;330-336.
6. Dana M.R., Dai R., Zhu S., Yamada J., Streilein J.W. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege. Invest. Ophthalmol. Vis. Sci. 39:1998;70-77.
7. Dana M.R., Streilein J.W. Loss and restoration of immune privilege in eyes with corneal neovascularization. Invest. Ophthalmol. Vis. Sci. 37:1996;2485-2494.
8. Dana M.R., Yamada J., Streilein J.W. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation. 63:1997;1501-1507.
9. Dana M.R., Zhu S.N., Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea. 17:1998;403-409.
10. Elner V.M., Strieter R.M., Pavilack M.A., Elner S.G., Remick D.G., Danforth J.M., Kunkel S.L. Human corneal interleukin-8. IL-1 and TNF-induced gene expression and secretion. Am. J. Pathol. 139:1991;977-988.
11. Giovine F.S., Duff G.W. Interleukin 1: the first interleukin. Immunol. Today. 11:1990;13-20.
12. 4+ T cells. J. Exp. Med. 184:1996;19-29.
13. Hannum C.H., Wilcox C.J., Arend W.P., Joslin F.G., Dripps D.J., Heimdal P.L., Armes L.G., Sommer A., Eisenberg S.P., Thompson R.C. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 343:1990;336-340.
14. Hu D.E., Hori Y., Presta M., Gresham G.A., Fan T.P. Inhibition of angiogenesis in rats by IL-1 receptor antagonist and selected cytokine antibodies. Inflammation. 18:1994;45-58.
15. Imanishi J., Kamiyama K., Iguchi I., Kita M., Sotozono C., Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog. Retin. Eye Res. 19:2000;113-129.
16. Kao W.W., Ebert J., Kao C.W., Covington H., Cintron C. Development of monoclonal antibodies recognizing collagenase from rabbit PMN; the presence of this enzyme in ulcerating corneas. Curr. Eye Res. 5:1986;801-815.
17. Kennedy M.C., Rosenbaum J.T., Brown J., Planck S.R., Huang X., Armstrong C.A., Ansel J.C. Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J. Clin. Invest. 95:1995;82-88.
18. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc. Nat. Acad. Sci. USA. 89:1992;9117-9120.
19. Koch A.E., Polverini P.J., Leibovich J.L. Induction of neovascularization by activated human monocytes. J. Leukoc. Biol. 55:1986;410-422.
20. Matsuda H., Smelser G.K. Epithelium and stroma in alkali-burned corneas. Arch. Ophthalmol. 89:1973;396-401.
21. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Ann. Rev. Immunol. 11:1993;165-190.
22. Niederkorn J.Y., Peeler J.S., Mellon J. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg. Immunol. 2:1989;83-90.
23. Ohlsson K., Bjork P., Bergenfeldt M., Hageman R., Thompson R.C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 348:1990;550-552.
24. Ormerod L.D., Abelson M.B., Kenyon K.R. Standard models of corneal injury using alkali-immersed filter discs. Invest. Ophthalmol. Vis. Sci. 30:1989;2148-2153.
25. Paterson C.A., Wells J.G., Koklitis P.A., Higgs G.A., Docherty A.J. Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkali-burn-induced corneal ulceration in rabbits. Invest. Ophthalmol. Vis. Sci. 35:1994;677-684.
26. Pfister R.R., Haddox J.L., Sommers C.I. Effect of synthetic metalloproteinase inhibitor or citrate on neutrophil chemotaxis and the respiratory burst. Invest. Ophthalmol. Vis. Sci. 38:1997;1340-1349.
27. Reim M., Beil K.H., Kammerer G., Krehwinkel S. Influence of systemic ascorbic acid treatment on metabolite levels after regeneration of the corneal epithelium following mild alkali burns. Graefe's. Arch. Clin. Exp. Ophthalmol. 218:1982;99-102.
28. Sato Y., Ohshima T., Kondo T. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem. Biophys. Res. Commun. 265:1999;194-199.
29. Sonoda Y., Streilein J.W. Orthotopic corneal transplantation in mice - evidence that the immunogenetic rules of rejection do not apply. Transplantation. 54:1992;694-704.
30. Sotozono C. Second injury in the cornea. Cornea. 19:2000;S155-S159.
31. Sotozono C., He J., Matsumoto Y., Kita M., Imanishi J., Kinoshita S. Cytokine expression in the alkali-burned cornea. Curr. Eye Res. 16:1997;670-676.
32. Strieter R.M., Kunkel S.L., Elner V.M., Martonyi C.L., Koch A.E., Polverini P.J., Elner S.G. Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141:1992;1279-1284.
33. Tran M.T., Tellaetxe-Isusi M., Elner V., Strieter R.M., Lausch R.N., Oakes J.E. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. Beta-chemokine synthesis in corneal cells. Invest. Ophthalmol. Vis. Sci. 37:1996;987-996.
34. Wagoner M.D. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv. Ophthalmol. 41:1997;275-313.
35. West-Mays J.A., Sadow P.M., Tobin T.W., Strissel K.J., Cintron C., Fini M.E. Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 alpha autocrine feedback loop. Invest. Ophthalmol. Vis. Sci. 38:1997;1367-1379.
36. West-Mays J.A., Strissel K.J., Sadow P.M., Fini M.E. Competence for collagenase gene expression by tissue fibroblasts requires activation of an interleukin 1 alpha autocrine loop. Proc. Nat. Acad. Sci. USA. 92:1995;6768-6772.
37. Wlaschek M., Heinen G., Poswig A., Schwarz A., Krieg T., Scharffetter-Kochanek K. UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem. Photobiol. 59:1994;550-556.
38. Yamada J., Dana M.R., Zhu S.N., Alard P., Streilein J.W. Interleukin-1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch. Ophthalmol. 116:1998;1351-1357.
39. Zhu S.N., Dana M.R. Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization. Invest. Ophthalmol. Vis. Sci. 40:1999;1427-1434.